Literature DB >> 6804464

Interactions of the tau-tubulin-vinblastine complex with colchicine, podophyllotoxin, and N,N'-ethylenebis(iodoacetamide).

P Palanivelu, R F Ludueña.   

Abstract

Microtubule assembly is inhibited by anti-mitotic drugs such as colchicine or podophyllotoxin and also by sulfhydryl-oxidizing reagents, but it is not known which tubulin-tubulin interactions are disrupted by these agents. We have studied the interactions of a complex of tubulin, vinblastine, and tau protein with these agents. This complex has the form of a spiral filament and may consist of tubulin dimers joined end to end as in a protofilament; presumably, therefore, the lateral interaction sites should be accessible in this structure but not in the intact microtubule. Unlike the microtubule, the complex binds to colchicine and podophyllotoxin with high affinity. Again, unlike intact microtubules, the complex reacts with N,N'-ethylene-bis(iodoacetamide) to generate an intra-chain cross-link in beta-tubulin. Tubulin molecules containing this cross-link are unable to polymerize, suggesting that formation of this cross-link involves sulfhydryl groups that are critical for assembly. These results are consistent with a model whereby colchicine-, podophyllotoxin-, and sulfhydryl-oxidizing agents inhibit microtubule assembly by preventing lateral interactions between tubulin molecules in adjacent protofilaments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804464

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Temperature sensitivity of vinblastine-induced tubulin polymerization in the presence of microtubule-associated proteins.

Authors:  V Prasad; M A Jordan; R F Ludueña
Journal:  J Protein Chem       Date:  1992-10

2.  Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules.

Authors:  A Vandecandelaere; S R Martin; Y Engelborghs
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Nuclear βII-Tubulin and its Possible Utility in Cancer Diagnosis, Prognosis and Treatment.

Authors:  Richard F Ludueña; Consuelo Walss-Bass; Anna Portyanko; Jiayan Guo; I-Tien Yeh
Journal:  Front Cell Dev Biol       Date:  2022-05-30

4.  Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.

Authors:  Weiwei Wang; Hangxiao Zhang; Xumin Wang; Jordan Patterson; Philip Winter; Kathryn Graham; Sunita Ghosh; John C Lee; Christos D Katsetos; John R Mackey; Jack A Tuszynski; Gane Ka-Shu Wong; Richard F Ludueña
Journal:  Protoplasma       Date:  2016-12-09       Impact factor: 3.356

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.